| Use of proteomic patterns in serum to identify ovarian cancer EF Petricoin, AM Ardekani, BA Hitt, PJ Levine, VA Fusaro, SM Steinberg, ... The lancet 359 (9306), 572-577, 2002 | 4480 | 2002 |
| Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse SR Hingorani, EF Petricoin, A Maitra, V Rajapakse, C King, MA Jacobetz, ... Cancer cell 4 (6), 437-450, 2003 | 2878 | 2003 |
| Proteomic applications for the early detection of cancer JD Wulfkuhle, LA Liotta, EF Petricoin Nature reviews cancer 3 (4), 267-275, 2003 | 1239 | 2003 |
| Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front CP Paweletz, L Charboneau, VE Bichsel, NL Simone, T Chen, ... Oncogene 20 (16), 1981-1989, 2001 | 1184 | 2001 |
| Serum proteomic patterns for detection of prostate cancer EF Petricoin III, DK Ornstein, CP Paweletz, A Ardekani, PS Hackett, ... Journal of the National Cancer Institute 94 (20), 1576-1578, 2002 | 975 | 2002 |
| Laser-capture microdissection V Espina, JD Wulfkuhle, VS Calvert, A VanMeter, W Zhou, G Coukos, ... Nature protocols 1 (2), 586-603, 2006 | 959 | 2006 |
| Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance J Zhou, J Wulfkuhle, H Zhang, P Gu, Y Yang, J Deng, JB Margolick, ... Proceedings of the National Academy of Sciences 104 (41), 16158-16163, 2007 | 806 | 2007 |
| Clinical proteomics: translating benchside promise into bedside reality EF Petricoin, KC Zoon, EC Kohn, JC Barrett, LA Liotta Nature reviews Drug discovery 1 (9), 683-695, 2002 | 730 | 2002 |
| Clinical proteomics: written in blood LA Liotta, M Ferrari, E Petricoin Nature 425 (6961), 905-905, 2003 | 686 | 2003 |
| Requirement for MAP kinase (ERK2) activity in interferon α-and interferon β-stimulated gene expression through STAT proteins M David, E Petricoin III, C Benjamin, R Pine, MJ Weber, AC Larner Science 269 (5231), 1721-1723, 1995 | 684 | 1995 |
| Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer KL Bryant, CA Stalnecker, D Zeitouni, JE Klomp, S Peng, AP Tikunov, ... Nature medicine 25 (4), 628-640, 2019 | 611 | 2019 |
| 2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers G Zhou, H Li, D DeCamp, S Chen, H Shu, Y Gong, M Flaig, JW Gillespie, ... Molecular & Cellular Proteomics 1 (2), 117-123, 2002 | 610 | 2002 |
| Molecular profiling of human cancer L Liotta, E Petricoin Nature Reviews Genetics 1 (1), 48-56, 2000 | 604 | 2000 |
| Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. CM Bacon, EF Petricoin 3rd, JR Ortaldo, RC Rees, AC Larner, ... Proceedings of the National Academy of Sciences 92 (16), 7307-7311, 1995 | 583 | 1995 |
| Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays S Nishizuka, L Charboneau, L Young, S Major, WC Reinhold, M Waltham, ... Proceedings of the National Academy of Sciences 100 (24), 14229-14234, 2003 | 572 | 2003 |
| Protein microarrays: meeting analytical challenges for clinical applications LA Liotta, V Espina, AI Mehta, V Calvert, K Rosenblatt, D Geho, ... Cancer cell 3 (4), 317-325, 2003 | 571 | 2003 |
| SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer EF Petricoin, LA Liotta Current Opinion in Biotechnology 15 (1), 24-30, 2004 | 494 | 2004 |
| Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment P Iyengar, V Espina, TW Williams, Y Lin, D Berry, LA Jelicks, H Lee, ... The Journal of clinical investigation 115 (5), 1163-1176, 2005 | 485 | 2005 |
| Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial MJ Pishvaian, EM Blais, JR Brody, E Lyons, P DeArbeloa, A Hendifar, ... The Lancet Oncology 21 (4), 508-518, 2020 | 473 | 2020 |
| Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer MB Jones, H Krutzsch, H Shu, Y Zhao, LA Liotta, EC Kohn, EF Petricoin III PROTEOMICS: International Edition 2 (1), 76-84, 2002 | 471 | 2002 |
Lance LiottaProfessor George Mason Universityכתובת אימייל מאומתת בדומיין gmu.edu